Predicting response to EGFR inhibitors in metastatic colorectal cancer: current practice and future directions.
Oncologist., 15(2):157-67 (2010)
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?
J. Clin. Oncol., Sep;27(26):4398-405 (2009)
Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening.
J. Clin. Oncol., Nov;25(33):5248-53 (2007)